Report Detail

Pharma & Healthcare Global (United States, European Union and China) Lanreotide Market Research Report 2019-2025

  • RnM3641275
  • |
  • 02 August, 2019
  • |
  • Global
  • |
  • 113 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Lanreotide (INN) is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome
In 2019, the market size of Lanreotide is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Lanreotide.

This report studies the global market size of Lanreotide, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Lanreotide sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
IPSEN
...

Market Segment by Product Type
60 mg
90 mg
120 mg

Market Segment by Application
Hospital
Pharmacy

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Lanreotide status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Lanreotide manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Lanreotide are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025


Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Lanreotide Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 60 mg
      • 1.3.3 90 mg
      • 1.3.4 120 mg
    • 1.4 Market Segment by Application
      • 1.4.1 Global Lanreotide Market Share by Application (2019-2025)
      • 1.4.2 Hospital
      • 1.4.3 Pharmacy
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Lanreotide Market Size
      • 2.1.1 Global Lanreotide Revenue 2014-2025
      • 2.1.2 Global Lanreotide Sales 2014-2025
    • 2.2 Lanreotide Growth Rate by Regions
      • 2.2.1 Global Lanreotide Sales by Regions 2014-2019
      • 2.2.2 Global Lanreotide Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Lanreotide Sales by Manufacturers
      • 3.1.1 Lanreotide Sales by Manufacturers 2014-2019
      • 3.1.2 Lanreotide Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Lanreotide Revenue by Manufacturers (2014-2019)
      • 3.2.2 Lanreotide Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Lanreotide Market Concentration Ratio (CR5 and HHI)
    • 3.3 Lanreotide Price by Manufacturers
    • 3.4 Key Manufacturers Lanreotide Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Lanreotide Market
    • 3.6 Key Manufacturers Lanreotide Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 60 mg Sales and Revenue (2014-2019)
      • 4.1.2 90 mg Sales and Revenue (2014-2019)
      • 4.1.3 120 mg Sales and Revenue (2014-2019)
    • 4.2 Global Lanreotide Sales Market Share by Type
    • 4.3 Global Lanreotide Revenue Market Share by Type
    • 4.4 Lanreotide Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Lanreotide Sales by Application

    6 United States

    • 6.1 United States Lanreotide Breakdown Data by Company
    • 6.2 United States Lanreotide Breakdown Data by Type
    • 6.3 United States Lanreotide Breakdown Data by Application

    7 European Union

    • 7.1 European Union Lanreotide Breakdown Data by Company
    • 7.2 European Union Lanreotide Breakdown Data by Type
    • 7.3 European Union Lanreotide Breakdown Data by Application

    8 China

    • 8.1 China Lanreotide Breakdown Data by Company
    • 8.2 China Lanreotide Breakdown Data by Type
    • 8.3 China Lanreotide Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Lanreotide Breakdown Data by Company
    • 9.2 Rest of World Lanreotide Breakdown Data by Type
    • 9.3 Rest of World Lanreotide Breakdown Data by Application
    • 9.4 Rest of World Lanreotide Breakdown Data by Countries
      • 9.4.1 Rest of World Lanreotide Sales by Countries
      • 9.4.2 Rest of World Lanreotide Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 IPSEN
      • 10.1.1 IPSEN Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Lanreotide
      • 10.1.4 Lanreotide Product Introduction
      • 10.1.5 IPSEN Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Lanreotide Sales Channels
      • 11.2.2 Lanreotide Distributors
    • 11.3 Lanreotide Customers

    12 Market Forecast

    • 12.1 Global Lanreotide Sales and Revenue Forecast 2019-2025
    • 12.2 Global Lanreotide Sales Forecast by Type
    • 12.3 Global Lanreotide Sales Forecast by Application
    • 12.4 Lanreotide Forecast by Regions
      • 12.4.1 Global Lanreotide Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Lanreotide Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Summary:
      Get latest Market Research Reports on Lanreotide. Industry analysis & Market Report on Lanreotide is a syndicated market report, published as Global (United States, European Union and China) Lanreotide Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Lanreotide market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,280.00
      $4,920.00
      $6,560.00
      2,578.08
      3,867.12
      5,156.16
      3,030.72
      4,546.08
      6,061.44
      513,582.40
      770,373.60
      1,027,164.80
      273,191.20
      409,786.80
      546,382.40
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report